Peri-operative Oral Pain Control Following Buccal Graft Urethroplasty

计划入组 60 人 · 首次发布于 2022 年 3 月 29 日

Local Anesthetic Treatment of Oral Pain in Patients With Mucositis

计划入组 70 人 · 首次发布于 2014 年 9 月 30 日

Reduction in Pain Intensity Following IV or Oral Pain-relieving Products

计划入组 79 人 · 首次发布于 2016 年 2 月 9 日

ion channel inhibitor (oral, pain)

TRPA1 antagonists (oral, pain/respiratory diseases)

SST4 receptor agonists (oral, neuropathic pain/inflammation)

PAIN THERAPEUTICS

United States

Oral-B Laboratories

United States

Philips Oral Healthcare

United States

OncoZenge Submits Phase III Clinical Trial Application for BupiZenge in Cancer-Related Oral Pain

OncoZenge Partners with Meribel Pharma for BupiZenge Phase 3 Manufacturing

OncoZenge Secures $2.9 Million Investment to Advance Phase 3 Trial of BupiZenge for Oral Mucositis Pain